Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)

Assessmet of Patients With PAH Right Ventricular Volume
Assessment of Right Ventricular Volume Using the Ventripoint Medical System in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/5/2012
Cleveland Clinic
mi
from
Cleveland, OH
Assessmet of Patients With PAH Right Ventricular Volume
Assessment of Right Ventricular Volume Using the Ventripoint Medical System in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/5/2012
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Assessmet of Patients With PAH Right Ventricular Volume
Assessment of Right Ventricular Volume Using the Ventripoint Medical System in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/5/2012
Allegheny General Hospital
mi
from
Pittsburgh, PA
Assessmet of Patients With PAH Right Ventricular Volume
Assessment of Right Ventricular Volume Using the Ventripoint Medical System in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/5/2012
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Assessmet of Patients With PAH Right Ventricular Volume
Assessment of Right Ventricular Volume Using the Ventripoint Medical System in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  10/5/2012
Baylor
mi
from
Dallas, TX
Assessmet of Patients With PAH Right Ventricular Volume
Assessment of Right Ventricular Volume Using the Ventripoint Medical System in Patients With Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 10/5/2012
Baylor
mi
from
Dallas, TX
Click here to add this to my saved trials
Veterans Service Organizations and MHV
Working With Veterans Organizations to Encourage Use of My HealtheVet
Status: Enrolling
Updated:  10/12/2012
Clement J. Zablocki VAMC
mi
from
Milwaukee, WI
Veterans Service Organizations and MHV
Working With Veterans Organizations to Encourage Use of My HealtheVet
Status: Enrolling
Updated: 10/12/2012
Clement J. Zablocki VAMC
mi
from
Milwaukee, WI
Click here to add this to my saved trials
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Status: Enrolling
Updated:  10/31/2012
Pfizer Investigational Site
mi
from
Los Angeles, CA
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Status: Enrolling
Updated: 10/31/2012
Pfizer Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Status: Enrolling
Updated:  10/31/2012
Pfizer Investigational Site
mi
from
Arvada, CO
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Status: Enrolling
Updated: 10/31/2012
Pfizer Investigational Site
mi
from
Arvada, CO
Click here to add this to my saved trials
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Status: Enrolling
Updated:  10/31/2012
Pfizer Investigational Site
mi
from
Boston, MA
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Status: Enrolling
Updated: 10/31/2012
Pfizer Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Status: Enrolling
Updated:  10/31/2012
Pfizer Investigational Site
mi
from
Detroit, MI
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Status: Enrolling
Updated: 10/31/2012
Pfizer Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Status: Enrolling
Updated:  10/31/2012
Pfizer Investigational Site
mi
from
Cape Girardeau, MO
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Status: Enrolling
Updated: 10/31/2012
Pfizer Investigational Site
mi
from
Cape Girardeau, MO
Click here to add this to my saved trials
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Status: Enrolling
Updated:  10/31/2012
Pfizer Investigational Site
mi
from
Rochester, NY
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Status: Enrolling
Updated: 10/31/2012
Pfizer Investigational Site
mi
from
Rochester, NY
Click here to add this to my saved trials
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Status: Enrolling
Updated:  10/31/2012
Pfizer Investigational Site
mi
from
Akron, OH
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Status: Enrolling
Updated: 10/31/2012
Pfizer Investigational Site
mi
from
Akron, OH
Click here to add this to my saved trials
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Status: Enrolling
Updated:  10/31/2012
Pfizer Investigational Site
mi
from
Anderson, SC
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Status: Enrolling
Updated: 10/31/2012
Pfizer Investigational Site
mi
from
Anderson, SC
Click here to add this to my saved trials
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Status: Enrolling
Updated:  10/31/2012
Pfizer Investigational Site
mi
from
Seattle, WA
A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil Citrate In The Treatment Of Subjects Who Have Completed Study A1481131
Status: Enrolling
Updated: 10/31/2012
Pfizer Investigational Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Tailored Case Management for Diabetes and Hypertension
Tailored Case Management for Diabetes and Hypertension
Status: Enrolling
Updated:  11/9/2012
Duke Univ Med Ctr
mi
from
Durham, NC
Tailored Case Management for Diabetes and Hypertension
Tailored Case Management for Diabetes and Hypertension
Status: Enrolling
Updated: 11/9/2012
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated:  11/15/2012
Kenneth Sall, M.D.
mi
from
Artesia, CA
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated: 11/15/2012
Kenneth Sall, M.D.
mi
from
Artesia, CA
Click here to add this to my saved trials
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated:  11/15/2012
Aesthetic Eye Care Institute
mi
from
Newport Beach, CA
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated: 11/15/2012
Aesthetic Eye Care Institute
mi
from
Newport Beach, CA
Click here to add this to my saved trials
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated:  11/15/2012
Bacharach practice
mi
from
Petaluma, CA
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated: 11/15/2012
Bacharach practice
mi
from
Petaluma, CA
Click here to add this to my saved trials
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated:  11/15/2012
Clayton Eye Center
mi
from
Morrow, GA
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated: 11/15/2012
Clayton Eye Center
mi
from
Morrow, GA
Click here to add this to my saved trials
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated:  11/15/2012
Coastal Research Associates, LLC
mi
from
Roswell, GA
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated: 11/15/2012
Coastal Research Associates, LLC
mi
from
Roswell, GA
Click here to add this to my saved trials
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated:  11/15/2012
Bradley Kwapiszeski, MD
mi
from
Shawnee Mission, KA
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated: 11/15/2012
Bradley Kwapiszeski, MD
mi
from
Shawnee Mission, KA
Click here to add this to my saved trials
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated:  11/15/2012
Taustine Eye Center
mi
from
Louisville, KY
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated: 11/15/2012
Taustine Eye Center
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated:  11/15/2012
Rochester Ophthalmological Group
mi
from
Rochester, NY
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated: 11/15/2012
Rochester Ophthalmological Group
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated:  11/15/2012
Charlotte Eye Ear Nose and Throat
mi
from
Charlotte, NC
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated: 11/15/2012
Charlotte Eye Ear Nose and Throat
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated:  11/15/2012
Michael E. Tepedino, M.D.
mi
from
High Point, NC
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated: 11/15/2012
Michael E. Tepedino, M.D.
mi
from
High Point, NC
Click here to add this to my saved trials
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated:  11/15/2012
The Eye Institute
mi
from
Tulsa, OK
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated: 11/15/2012
The Eye Institute
mi
from
Tulsa, OK
Click here to add this to my saved trials
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated:  11/15/2012
Texan Eye
mi
from
Austin, TX
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated: 11/15/2012
Texan Eye
mi
from
Austin, TX
Click here to add this to my saved trials
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated:  11/15/2012
Cataract & Glaucoma Center
mi
from
El Paso, TX
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated: 11/15/2012
Cataract & Glaucoma Center
mi
from
El Paso, TX
Click here to add this to my saved trials
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated:  11/15/2012
Medical Center Ophth. Associates
mi
from
San Antonio, TX
A Study Assessing the Safety and Ocular Hypotensive Efficacy of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Phase 2b Dose-response of AR-12286 in Patients With Elevated Intraocular Pressure for 3 Months
Status: Enrolling
Updated: 11/15/2012
Medical Center Ophth. Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
A Phase 2a, Randomized, Double-masked, Placebo-controlled, Dose-escalation Study of AMA0076 in Topical Ocular Formulation for Safety, Tolerability and Efficacy in Reduction of Intraocular Pressure in Subjects With Ocular Hypertension or Primary Open-angle Glaucoma
Status: Enrolling
Updated:  11/23/2012
Artesia Clinical Site - Site 02
mi
from
Artesia, CA
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
A Phase 2a, Randomized, Double-masked, Placebo-controlled, Dose-escalation Study of AMA0076 in Topical Ocular Formulation for Safety, Tolerability and Efficacy in Reduction of Intraocular Pressure in Subjects With Ocular Hypertension or Primary Open-angle Glaucoma
Status: Enrolling
Updated: 11/23/2012
Artesia Clinical Site - Site 02
mi
from
Artesia, CA
Click here to add this to my saved trials
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
A Phase 2a, Randomized, Double-masked, Placebo-controlled, Dose-escalation Study of AMA0076 in Topical Ocular Formulation for Safety, Tolerability and Efficacy in Reduction of Intraocular Pressure in Subjects With Ocular Hypertension or Primary Open-angle Glaucoma
Status: Enrolling
Updated:  11/23/2012
Inglewood Clinical Site - Site 03
mi
from
Inglewood, CA
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
A Phase 2a, Randomized, Double-masked, Placebo-controlled, Dose-escalation Study of AMA0076 in Topical Ocular Formulation for Safety, Tolerability and Efficacy in Reduction of Intraocular Pressure in Subjects With Ocular Hypertension or Primary Open-angle Glaucoma
Status: Enrolling
Updated: 11/23/2012
Inglewood Clinical Site - Site 03
mi
from
Inglewood, CA
Click here to add this to my saved trials
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
A Phase 2a, Randomized, Double-masked, Placebo-controlled, Dose-escalation Study of AMA0076 in Topical Ocular Formulation for Safety, Tolerability and Efficacy in Reduction of Intraocular Pressure in Subjects With Ocular Hypertension or Primary Open-angle Glaucoma
Status: Enrolling
Updated:  11/23/2012
Petaluma Clinical Site - Site 05
mi
from
Petaluma, CA
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
A Phase 2a, Randomized, Double-masked, Placebo-controlled, Dose-escalation Study of AMA0076 in Topical Ocular Formulation for Safety, Tolerability and Efficacy in Reduction of Intraocular Pressure in Subjects With Ocular Hypertension or Primary Open-angle Glaucoma
Status: Enrolling
Updated: 11/23/2012
Petaluma Clinical Site - Site 05
mi
from
Petaluma, CA
Click here to add this to my saved trials
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
A Phase 2a, Randomized, Double-masked, Placebo-controlled, Dose-escalation Study of AMA0076 in Topical Ocular Formulation for Safety, Tolerability and Efficacy in Reduction of Intraocular Pressure in Subjects With Ocular Hypertension or Primary Open-angle Glaucoma
Status: Enrolling
Updated:  11/23/2012
New Haven Clinical Site - Site 01
mi
from
New Haven, CT
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
A Phase 2a, Randomized, Double-masked, Placebo-controlled, Dose-escalation Study of AMA0076 in Topical Ocular Formulation for Safety, Tolerability and Efficacy in Reduction of Intraocular Pressure in Subjects With Ocular Hypertension or Primary Open-angle Glaucoma
Status: Enrolling
Updated: 11/23/2012
New Haven Clinical Site - Site 01
mi
from
New Haven, CT
Click here to add this to my saved trials
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
A Phase 2a, Randomized, Double-masked, Placebo-controlled, Dose-escalation Study of AMA0076 in Topical Ocular Formulation for Safety, Tolerability and Efficacy in Reduction of Intraocular Pressure in Subjects With Ocular Hypertension or Primary Open-angle Glaucoma
Status: Enrolling
Updated:  11/23/2012
Atlanta Clinical Site - Site 04
mi
from
Atlanta, GA
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
A Phase 2a, Randomized, Double-masked, Placebo-controlled, Dose-escalation Study of AMA0076 in Topical Ocular Formulation for Safety, Tolerability and Efficacy in Reduction of Intraocular Pressure in Subjects With Ocular Hypertension or Primary Open-angle Glaucoma
Status: Enrolling
Updated: 11/23/2012
Atlanta Clinical Site - Site 04
mi
from
Atlanta, GA
Click here to add this to my saved trials
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
A Phase 2a, Randomized, Double-masked, Placebo-controlled, Dose-escalation Study of AMA0076 in Topical Ocular Formulation for Safety, Tolerability and Efficacy in Reduction of Intraocular Pressure in Subjects With Ocular Hypertension or Primary Open-angle Glaucoma
Status: Enrolling
Updated:  11/23/2012
High Point Clinical Site - Site 06
mi
from
High Point, NC
Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma
A Phase 2a, Randomized, Double-masked, Placebo-controlled, Dose-escalation Study of AMA0076 in Topical Ocular Formulation for Safety, Tolerability and Efficacy in Reduction of Intraocular Pressure in Subjects With Ocular Hypertension or Primary Open-angle Glaucoma
Status: Enrolling
Updated: 11/23/2012
High Point Clinical Site - Site 06
mi
from
High Point, NC
Click here to add this to my saved trials
Coenzyme Q-10 and Pulmonary Arterial Hypertension
Coenzyme Q-10 in the Treatment of Pulmonary Arterial Hypertension
Status: Enrolling
Updated:  11/29/2012
Cleveland Clinic
mi
from
Cleveland, OH
Coenzyme Q-10 and Pulmonary Arterial Hypertension
Coenzyme Q-10 in the Treatment of Pulmonary Arterial Hypertension
Status: Enrolling
Updated: 11/29/2012
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension
A Phase I/II Dose Escalation Safety and Efficacy Trial of DE-112 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/14/2012
Clinical Research Facility
mi
from
Austin, TX
Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension
A Phase I/II Dose Escalation Safety and Efficacy Trial of DE-112 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/14/2012
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension
A Phase I/II Dose Escalation Safety and Efficacy Trial of DE-112 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated:  12/14/2012
Clinical Research Facility
mi
from
San Antonio, TX
Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension
A Phase I/II Dose Escalation Safety and Efficacy Trial of DE-112 Ophthalmic Solution in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension
Status: Enrolling
Updated: 12/14/2012
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
University of Arizona
mi
from
Tucson, AZ
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
University of Arizona
mi
from
Tucson, AZ
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
University of California at Los Angeles
mi
from
Los Angeles, CA
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
Leland Stanford Junior University
mi
from
Palo Alto, CA
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Leland Stanford Junior University
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
Piedmont Hospital, Incorporated
mi
from
Atlanta, GA
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Piedmont Hospital, Incorporated
mi
from
Atlanta, GA
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
Northwestern University
mi
from
Chicago, IL
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
Rush University Medical Center
mi
from
Chicago, IL
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
Indiana University
mi
from
Indianapolis, IN
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
University of Kansas Medical Center Research Institute, Inc.
mi
from
Kansas City, KA
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
University of Kansas Medical Center Research Institute, Inc.
mi
from
Kansas City, KA
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
University of Maryland, Baltimore
mi
from
Baltimore, MD
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
University of Maryland, Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
University of Michigan
mi
from
Ann Arbor, MI
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
University of Washington School of Medicine - Barnes-Jewish Hospital
mi
from
St Louis, MO
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
University of Washington School of Medicine - Barnes-Jewish Hospital
mi
from
St Louis, MO
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
Mt. Sinai Medical Center
mi
from
New York, NY
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Mt. Sinai Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated:  12/19/2012
Duke Univ Med Ctr
mi
from
Durham, NC
Early TIPS for Ascites Study
The GORE® VIATORR® TIPS Endoprosthesis Versus Large-Volume Paracentesis for the Treatment of Ascites in Patients With Portal Hypertension
Status: Enrolling
Updated: 12/19/2012
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials